AN EFFICACY AND SAFETY STUDY OF JNJ-64041757, A LIVE ATTENUATED LISTERIA MONOCYTOGENES IMMUNOTHERAPY, IN COMBINATION WITH NIVOLUMAB VERSUS NIVOLUMAB MONOTHERAPY IN PARTICIPANTS WITH ADVANCED ADENOCARCINOMA OF THE LUNG: